Ticker >

Akums Drugs & Pharmaceuticals share price

Akums Drugs & Pharmaceuticals Ltd.

NSE: AKUMS BSE: 544222 SECTOR: Pharmaceuticals & Drugs  8216   4   2

848.60
+3.00 (0.35%)
NSE: Today, 12:34 PM

Price Summary

Today's High

₹ 852

Today's Low

₹ 835

52 Week High

₹ 1175.9

52 Week Low

₹ 725

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

13356.45 Cr.

Enterprise Value

13493.19 Cr.

No. of Shares

15.74 Cr.

P/E

106.48

P/B

0

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  0

CASH

8.85 Cr.

DEBT

145.59 Cr.

Promoter Holding

-

EPS (TTM)

₹  7.97

Sales Growth

10.74%

ROE

50.47 %

ROCE

42.75%

Profit Growth

132.85 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.74%
3 Year20.42%
5 Year16.65%

Profit Growth

1 Year132.85%
3 Year35.11%
5 Year13.12%

ROE%

1 Year50.47%
3 Year-24.57%
5 Year-11.57%

ROCE %

1 Year42.75%
3 Year-20.05%
5 Year-7.33%

Debt/Equity

0.4674

Price to Cash Flow

142.07

Interest Cover Ratio

12.4085

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Investors List Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 35.1074429673284% for the Past 3 years.
  • The company has shown a good revenue growth of 20.4209039791617% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 12.4085.
  • Company’s PEG ratio is 0.914610296301921.
  • The company has an efficient Cash Conversion Cycle of 33.2265 days.

 Limitations

  • Company has a poor ROE of -24.5736% over the past 3 years.
  • Company has a poor ROCE of -20.0455% over the past 3 years
  • The company has a low EBITDA margin of 1.55596% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 39.8495.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024
Net Sales 317.28
Total Expenditure 273.59
Operating Profit 43.68
Other Income 26.18
Interest 6.21
Depreciation 9.38
Exceptional Items 0
Profit Before Tax 54.27
Tax 12.4
Profit After Tax 41.88
Adjusted EPS (Rs) 2.93

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 683.08 736.91 837.44 1162.06 1286.83
Total Expenditure 601.16 696.98 810.73 1524.1 1050.88
Operating Profit 81.92 39.92 26.7 -362.04 235.95
Other Income 56.87 65.52 54.51 58.48 102.08
Interest 3.88 4.34 0.82 3.65 13.18
Depreciation 22.86 25.26 26.1 27.76 30
Exceptional Items 0 0 -249.5 0 -144.53
Profit Before Tax 112.05 75.85 -195.2 -334.98 150.32
Tax 37.21 24.99 -49.77 46.8 24.89
Net Profit 74.84 50.86 -145.43 -381.78 125.43
Adjusted EPS (Rs.) 5.79 3.55 -10.16 -26.69 8.77

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 1.18 1.3 1.3 14.31 28.61
Total Reserves 840.65 711.02 565.75 171.23 282.89
Borrowings 0 0 0 0 21.88
Other N/C liabilities 48.93 535.99 551.55 1092.56 1061.14
Current liabilities 155.54 177.95 146 535.86 496.56
Total Liabilities 1046.29 1426.26 1264.6 1813.95 1891.07
Assets
Net Block 220.16 225.84 229.09 233.5 253.15
Capital WIP 0 1.13 1.26 0.52 16.13
Intangible WIP 0 0 0 0 0.12
Investments 20.23 81.18 130.45 141.39 139.16
Loans & Advances 503.86 587.56 508.57 858.15 937.52
Other N/C Assets 0.32 36.41 24.63 25.24 23.92
Current Assets 301.73 494.14 370.6 555.16 521.08
Total Assets 1046.29 1426.26 1264.6 1813.95 1891.07
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 112.05 75.85 -195.2 -334.98 150.32
Adjustment -25.39 -26.46 -19.27 -11.93 -18.57
Changes in Assets & Liabilities -49.17 -22.68 -28.45 99.58 -81.51
Tax Paid -33.4 -46.32 -4.9 -7.19 -30.3
Operating Cash Flow 2.81 -21.75 55.57 228.31 94.01
Investing Cash Flow -14.78 -241.71 -99.96 -297.96 -202.17
Financing Cash Flow 15.35 301.53 2.6 94.99 89.9
Net Cash Flow 3.37 38.07 -41.79 25.34 -18.26

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
 No Investors Data available for this company.
Report us

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

Akums Drugs & Pharmaceuticals Stock Price Analysis and Quick Research Report. Is Akums Drugs & Pharmaceuticals an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Akums Drugs & Pharmaceuticals and its performance over the period of time. Akums Drugs & Pharmaceuticals stock price today is Rs 883.45.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Akums Drugs & Pharmaceuticals cash from the operating activity was Rs 94.013 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Akums Drugs & Pharmaceuticals has a Debt to Equity ratio of 0.4674 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Akums Drugs & Pharmaceuticals , the EPS growth was 132.8533 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Akums Drugs & Pharmaceuticals has OPM of 18.3355791692117 % which is a good sign for profitability.
     
  • ROE: Akums Drugs & Pharmaceuticals have a healthy ROE of 50.4707 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Akums Drugs & Pharmaceuticals is Rs 883.45. One can use valuation calculators of ticker to know if Akums Drugs & Pharmaceuticals share price is undervalued or overvalued.
Last Updated on:
Brief about Akums Drugs & Pharmaceuticals
X